Targetable alterations in bladder cancer

Siamak Daneshmand, MD, University of Southern California, Los Angeles, CA, talks on targetable alterations for bladder cancer, focusing on FGFR3. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.